CymaBay Therapeutics, Inc. (CBAY) Balance sheet

Market cap

$3.7B

P/E ratio

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12
Cash and cash equivalents	24	12	8	10	23	49	25	28	126	20	207
Marketable securities, current	7	-	-	6	74	130	166	118	61	115	188
Total cash & short-term investments	31	12	8	17	97	179	191	146	187	135	394
Accounts receivable, net	0	0	-	-	5	-	-	-	-	-	-
Total current assets	32	37	43	19	104	182	203	152	191	138	404
Property, plant and equipment, net	0	0	0	0	0	3	2	2	1	1	0
Marketable securities, non-current	-	-	-	-	-	-	-	-	8	-	22
Total non-current assets	0	0	0	1	1	5	3	2	11	4	31
Total assets	33	37	43	19	104	187	206	154	202	142	435
Accounts payable	1	2	1	1	1	2	3	0	3	1	4
Total current liabilities	9	20	6	9	16	14	18	10	18	15	37
Total non-current liabilities	4	3	9	6	3	2	2	1	51	90	106
Total liabilities	14	24	15	15	19	16	19	11	69	106	142
Common stock and paid-in capital	367	395	424	427	536	694	812	820	900	909	1,270
Retained earnings	-349	-381	-396	-423	-451	-523	-626	-677	-767	-873	-978
Stockholders' equity	19	14	28	4	85	170	186	143	133	36	292